Timothy Iafolla Dmd is categorized under Research and Development Laboratories in Germantown, MD and active since 2006.
Timothy Iafolla Dmd was established in 2006, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Dmd Timothy Iafolla at the company’s single location by writing to 14220 Cervantes Avenue, Germantown, Maryland MD 20874 or by phoning (240) 876-6824. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Timothy Iafolla Dmd |
| Contact Person: | Dmd Timothy Iafolla |
| Address: | 14220 Cervantes Avenue, Germantown, Maryland 20874 |
| Phone Number: | (240) 876-6824 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Timothy Iafolla Dmd was started in 2006 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Dmd Timothy Iafolla for inquiries that concern Timothy Iafolla Dmd by calling the company number (240) 876-6824, as your correspondence is most welcome. Additionally, the physical location of the single location of Timothy Iafolla Dmd can be found at the coordinates as well as the street address 14220 Cervantes Avenue in Germantown, Maryland 20874.
For its online presence, you may visit Timothy Iafolla Dmd’s website at and engage with its social media outlets through on Twitter and on Facebook.